Literature DB >> 15282658

Interactions of platelet factor 4 with the vessel wall.

Bruce S Sachais1, Abd Al-Roof Higazi, Douglas B Cines, Mortimer Poncz, M Anna Kowalska.   

Abstract

Platelet factor 4 (PF4) is a platelet-specific protein that is stored in platelet alpha granules and released following platelet activation. PF4 was the first chemokine that was isolated, but unlike other chemokines, it may not have a clear role in inflammation. Gathering evidence suggests that unlike other chemokines that bind to specific receptors, PF4's biology depends on its unusually high affinity for heparan sulfates and other negatively charged molecules at concentrations attained in the immediate vicinity of activated platelets. There has been one report that PF4 binds to CXCR3B, a chemokine receptor isoform that may be present in some vascular beds, but the biological relevance of this single observation is not clear. We propose that the main biological role of PF4 and the basis for its presence in the alpha granules of all known mammalian platelets is to neutralize surface heparan sulfate side-chains of glycosaminoglycans and to optimize thrombus development at sites of vascular injury. In addition, the binding of PF4 to surface glycosaminoglycans may also underlie its angiostatic and proatherogenic properties. Additionally, PF4 binds to several other proteins that are central to thrombosis, angiogenesis, and atherogenesis. These interactions may also contribute to its biological and pathobiological effects. Certainly, future studies using in vivo models to test biological relevance of each of these proposed mechanisms by which PF4 interacts with the vasculature are needed, as are studies to define the importance of PF4 binding to CXCR3B.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282658     DOI: 10.1055/s-2004-831048

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  20 in total

1.  Platelet factor 4 is a biomarker for lymphatic-promoted disorders.

Authors:  Wanshu Ma; Hyea Jin Gil; Noelia Escobedo; Alberto Benito-Martín; Pilar Ximénez-Embún; Javier Muñoz; Héctor Peinado; Stanley G Rockson; Guillermo Oliver
Journal:  JCI Insight       Date:  2020-07-09

Review 2.  The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity.

Authors:  R Colobran; R Pujol-Borrell; M P Armengol; M Juan
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

3.  Serum biomarkers in uncontrolled no heart-beating donors may identify kidneys that will never work after transplantation.

Authors:  Antonio J López-Farré; Juana María Santos-Sancho; Javier Modrego; Antonio Segura; José J Zamorano-León; Leyre Martín; Ana Sánchez-Fructuoso; Pablo Rodríguez-Sierra; Fernando Prados; Alonso Mateos; José Herrero; Francisco del Río; Alberto Barrientos
Journal:  J Nephrol       Date:  2015-05-14       Impact factor: 3.902

4.  An unexpected role for platelets in blocking Th17 differentiation.

Authors:  Ronjon Chakraverty
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

5.  Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection.

Authors:  Guanfang Shi; David J Field; Kyung-ae Ko; Sara Ture; Kalyan Srivastava; Scott Levy; M Anna Kowalska; Mortimer Poncz; Deborah J Fowell; Craig N Morrell
Journal:  J Clin Invest       Date:  2014-01-27       Impact factor: 14.808

6.  Mechanism of platelet factor 4 (PF4) deficiency with RUNX1 haplodeficiency: RUNX1 is a transcriptional regulator of PF4.

Authors:  K Aneja; G Jalagadugula; G Mao; A Singh; A K Rao
Journal:  J Thromb Haemost       Date:  2011-02       Impact factor: 5.824

Review 7.  Role of platelets in neuroinflammation: a wide-angle perspective.

Authors:  Lawrence L Horstman; Wenche Jy; Yeon S Ahn; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; J Steven Alexander; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2010-02-03       Impact factor: 8.322

8.  Platelet factor 4 regulation of monocyte KLF4 in experimental cerebral malaria.

Authors:  Kalyan Srivastava; David J Field; Angela Aggrey; Munekazu Yamakuchi; Craig N Morrell
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

Review 9.  Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.

Authors:  Giovanni Anfossi; Isabella Russo; Gabriella Doronzo; Alice Pomero; Mariella Trovati
Journal:  Mediators Inflamm       Date:  2010-06-28       Impact factor: 4.711

10.  Platelet factor 4 mediates inflammation in experimental cerebral malaria.

Authors:  Kalyan Srivastava; Ian A Cockburn; AnneMarie Swaim; Laura E Thompson; Abhai Tripathi; Craig A Fletcher; Erin M Shirk; Henry Sun; M Anna Kowalska; Karen Fox-Talbot; David Sullivan; Fidel Zavala; Craig N Morrell
Journal:  Cell Host Microbe       Date:  2008-08-14       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.